In March 2026, We performed 80 endometriosis surgeries. learn more > We performed 80 endometriosis surgeries. In March 2026, We performed 80 endometriosis surgeries. learn more >

Home > Neurosurgery > Brain Tumours

Brain Tumour

A brain tumour diagnosis changes everything in an instant and yet, with the right neurosurgical team, the right technology, and the right treatment plan, outcomes that once seemed impossible are now being achieved every day. Brain tumours encompass a broad spectrum of growths both benign and malignant arising within the brain tissue, its coverings, or the structures around it.

At Shree Hospitals, our dedicated intracranial tumour specialists deliver comprehensive Brain Tumour treatment in Mumbai, India from advanced imaging and precise surgical resection to radiosurgery, oncological therapy, and long-term neurological rehabilitation giving every patient and family the clearest path forward through an extraordinarily challenging diagnosis.

(24×7 Emergency Care)

1800-268-4000

(24×7 Emergency Care)

1800-268-4000

Our Approach to Managing Brain Tumours

Diagnose with precision. Operate with confidence. Support without limit.

Brain tumours are not a single disease they are a diverse family of over 120 distinct tumour types, each with its own biology, behaviour, location, and treatment implications. A slow-growing meningioma in an elderly patient managed with surveillance alone sits at one end of the spectrum; an aggressive glioblastoma in a young adult requiring surgery, radiotherapy, and chemotherapy sits at the other. What unites every case at Shree Hospitals is the same commitment: a thorough multidisciplinary evaluation before any decision is made, and a treatment plan built entirely around the individual patient.

Our approach to brain tumour diagnosis and neurosurgical care in Mumbai begins with the most advanced neuroimaging available and extends through surgery, adjuvant therapy, rehabilitation, and long-term surveillance. For malignant and benign brain tumour management and intervention, our neuro-oncology tumour board meets regularly to review every complex case, ensuring no patient's care is decided by one specialist in isolation.

Advanced Neuroimaging & Diagnostic Workup

MRI brain with contrast the primary imaging modality for neurological tumour symptoms evaluation and tumour characterisation
MRI spectroscopy and perfusion imaging to distinguish tumour from radiation necrosis, abscess, or demyelination
Functional MRI (fMRI) mapping eloquent cortex areas for language, motor, and memory function before surgery
Diffusion tensor imaging (DTI) white matter tractography to visualise critical neural pathways adjacent to the tumour
PET-CT brain for metabolic activity assessment and grading guidance in suspected high-grade tumours
CT-guided or MRI-guided stereotactic biopsy for lesions where resection is not immediately feasible tissue diagnosis is essential before oncological treatment

Multidisciplinary Neuro-Oncology Tumour Board

Every brain tumour case at Shree Hospitals is reviewed by our dedicated tumour board before a treatment plan is finalised:

Neurosurgeon, neuro-oncologist, radiation oncologist, neuroradiologist, neuropathologist, and neurologist
WHO tumour grading assigned following histopathological and molecular analysis IDH mutation, MGMT promoter methylation, and 1p/19q codeletion status guide treatment and prognosis
Treatment pathway agreed collectively surgery, radiosurgery, chemotherapy, or surveillance based on tumour type, grade, location, and patient fitness
Family meeting held after tumour board to communicate findings and recommendations clearly and compassionately

Neurosurgical Resection Brain tumour
Surgery and radiosurgery at Shree Hospitals is performed with the highest standards of safety and oncological intent:

Awake craniotomy for tumours in eloquent brain regions language, motor cortex, or sensory areas allowing real-time patient feedback during tumour removal
Intraoperative MRI real-time imaging during surgery to maximise tumour resection while protecting critical structures
Fluorescence-guided surgery using 5-ALA dye malignant tumour cells glow pink under blue light, enabling more complete resection
Intraoperative neuromonitoring continuous motor evoked potential and somatosensory monitoring throughout surgery
Neuronavigation GPS-like precision guidance system for approaching deep or complex tumours with minimal normal tissue disruption
Endoscopic approaches for intraventricular tumours and selected skull base lesions

Stereotactic Radiosurgery & Radiotherapy

For tumours where surgery is not feasible, or as adjuvant treatment following resection:

Stereotactic radiosurgery (SRS) highly focused, single-session radiation delivery to small tumours or residual disease as part of brain tumour surgery and radiosurgery at Shree Hospitals
Fractionated stereotactic radiotherapy (FSRT) for larger tumours requiring dose distribution over multiple sessions
Whole brain radiotherapy for multiple brain metastases palliative but meaningful in extending symptom-free survival
Proton therapy referral coordination for paediatric brain tumours requiring maximum normal tissue sparing
Radiation planning incorporating fMRI and DTI data to protect eloquent cortex and critical white matter tracts

Chemotherapy & Targeted Oncological Therapy

Temozolomide chemotherapy for high-grade glioma concurrent with radiotherapy and as adjuvant maintenance for 6 cycles
Bevacizumab for recurrent glioblastoma anti-angiogenic therapy targeting tumour blood vessel formation
Targeted therapy for tumours with actionable molecular alterations IDH inhibitors, BRAF/MEK inhibitors for relevant tumour subtypes
Intrathecal chemotherapy for leptomeningeal tumour spread
Tumour treating fields (TTFields) wearable device delivering alternating electrical fields to disrupt tumour cell division in glioblastoma

Rehabilitation, Surveillance & Supportive Care

Post-operative neurological rehabilitation physiotherapy, occupational therapy, speech therapy, and cognitive rehabilitation
MRI surveillance schedule every 3 months for high-grade tumours, every 6 to 12 months for low-grade lesions
Steroid management dexamethasone for peritumoral oedema, carefully tapered post-operatively
Anti-epileptic therapy for tumour-related seizures levetiracetam as first-line agent, monitored long-term
Psychological support and palliative care integration for patients with advanced or recurrent disease
Intracranial tumour specialist led follow-up ensuring continuity across all phases of Brain Tumour treatment in Mumbai, India

Happy Patients & Their Case Stories

A 42-year-old teacher from Dadar presented with new-onset seizures. MRI revealed a large left frontal glioma adjacent to the motor cortex. Awake craniotomy at Shree Hospitals achieved gross total resection with complete motor function preservation. She returned to teaching eight weeks after surgery.

Mr. Shyam . K

This 67-year-old retired gentleman had a large meningioma causing progressive memory difficulties. Following brain tumour diagnosis and neurosurgical care in Mumbai at Shree Hospitals including complete microsurgical resection his cognition recovered remarkably within three months of surgery.

Mr. Ketan . P

How to Identify Brain Tumours?

Brain tumour symptoms vary enormously depending on tumour location, size, and growth rate. Slow-growing benign tumours may cause remarkably few symptoms for years; rapidly growing malignant tumours can produce dramatic neurological change within weeks. These are the signs that demand urgent evaluation:

New or progressively worsening headaches particularly those worse in the morning, waking from sleep, or accompanied by vomiting classic neurological tumour symptoms of raised intracranial pressure
Seizures in a person with no prior epilepsy history a new seizure in an adult always requires MRI brain to exclude a structural cause
Progressive weakness or numbness in an arm, leg, or one side of the face suggesting tumour involvement of motor or sensory cortex
Speech difficulties problems finding words, understanding language, or producing fluent speech without a preceding stroke
Vision changes blurring, double vision, visual field loss, or sudden visual disturbance related to optic pathway or posterior fossa involvement
Personality or behavioural change frontal lobe tumours particularly affect judgement, emotional control, and social behaviour often noticed by family before the patient
Balance and coordination problems unsteady gait, frequent falls, or clumsiness suggesting cerebellar or brainstem involvement
Cognitive decline or memory impairment particularly in older patients where it may be misattributed to dementia before imaging is performed

Any new, progressive, or unexplained neurological symptom warrants urgent MRI brain evaluation. For Brain Tumour treatment in Mumbai, India, our neurology and neurosurgery team offers priority appointments with same-day imaging where clinically indicated.

Important FAQs : Brain Tumours

Are all brain tumours cancerous?

No. Approximately half of all brain tumours are benign meaning they do not invade surrounding tissue or spread elsewhere. However, even benign tumours can be life-threatening depending on their location, size, and rate of growth. Brain tumour diagnosis and neurosurgical care in Mumbai at Shree Hospitals accurately classifies every tumour through histopathological analysis before treatment is planned.

What is the difference between a primary and secondary brain tumour?

Primary brain tumours originate within the brain tissue itself gliomas, meningiomas, and pituitary tumours are examples. Secondary brain tumours brain metastases originate elsewhere in the body and spread to the brain. Both require specialist intracranial tumour specialist evaluation and distinct treatment approaches.

How is a brain tumour diagnosed at Shree Hospitals?

MRI brain with contrast is the primary diagnostic tool identifying tumour location, size, and characteristics. MRI spectroscopy, perfusion imaging, fMRI, and PET-CT provide additional information. Tissue diagnosis through biopsy or surgical resection confirms the tumour type and molecular profile for malignant and benign brain tumour management and intervention.

Can a brain tumour be completely removed?

Complete surgical removal gross total resection is achievable for many benign tumours including meningiomas and low-grade gliomas in accessible locations. High-grade gliomas infiltrate surrounding tissue, making complete removal impossible but maximal safe resection combined with brain tumour surgery and radiosurgery significantly extends survival and quality of life.

When should I see a specialist for headaches and neurological symptoms?

Any headache that is new in character, progressively worsening, associated with vomiting or visual changes, or accompanied by seizures, weakness, or speech difficulty requires urgent MRI brain. For Brain Tumour treatment in Mumbai, India, our neurology team offers priority consultation and same-day neuroimaging for concerning presentations.

Treatments For Brain Tumours at Shree Hospitals

Treatment is determined by tumour type, WHO grade, molecular profile, location, patient age, and functional status. No two brain tumour patients receive identical treatment every plan emerges from our multidisciplinary tumour board discussion.

Neurosurgical Resection(CGM)

The cornerstone of Brain Tumour treatment in Mumbai, India for most accessible tumours. Maximal safe resection reduces tumour burden, provides tissue for diagnosis, relieves mass effect, and significantly extends survival in high-grade tumours.

Stereotactic Radiosurgery (SRS)

Precisely targeted, high-dose radiation delivered in a single or few sessions to small tumours or residual disease part of brain tumour surgery and radiosurgery at Shree Hospitals. Ideal for brain metastases, small meningiomas, acoustic neuromas, and post-surgical residual high-grade glioma.

Chemotherapy & Temozolomide Protocol

Standard of care for high-grade glioma concurrent temozolomide with radiotherapy followed by 6 cycles of adjuvant temozolomide. Targeted molecular therapies and bevacizumab for recurrent or progressive disease form part of malignant and benign brain tumour management and intervention at Shree Hospitals.

Stereotactic Biopsy

For deep, eloquent, or surgically inaccessible tumours, CT or MRI-guided stereotactic needle biopsy provides tissue for accurate histopathological and molecular diagnosis guiding the entire subsequent oncological treatment plan without open craniotomy.